Complete Filing Data
Gossamer Bio, Inc. reported Stockholders Equity of -$122.76 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Gossamer Bio, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$170.4M | -$56.5M | -$179.8M | -$229.4M | -$234.0M | -$243.4M | -$180.3M | -$147.0M | -$6.8M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$6.3M | $1.5M | $224.0K | -$619.0K | -$554.0K | $341.0K | $319.0K | -$61.0K | |
| Operating Income Loss | -$170.7M | -$59.9M | -$183.8M | -$218.6M | -$216.1M | -$234.0M | -$186.1M | -$149.0M | -$6.7M |
| Research And Development Expense Excluding Acquired In Process Cost | $174.1M | $138.5M | $135.3M | $170.9M | $170.3M | $160.9M | $143.4M | $55.3M | $891.0K |
| Operating Expenses | $219.2M | $174.6M | $183.8M | $218.6M | $216.1M | $234.0M | $186.1M | $149.0M | $6.7M |
| General And Administrative Expense | $37.6M | $36.1M | $38.5M | $47.6M | $45.8M | $49.7M | $39.1M | $44.1M | $262.0K |
| Comprehensive Income Net Of Tax | -$176.7M | -$55.0M | -$179.6M | -$230.0M | -$234.6M | -$243.0M | -$180.0M | -$147.0M | -$6.8M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$90.0K | $89.0K | $191.0K | -$75.0K | -$225.0K | -$100.0K | $331.0K | -$61.0K | |
| Nonoperating Income Expense | $270.0K | $4.3M | $3.9M | -$10.8M | -$17.9M | $5.8M | $2.0M | -$118.0K | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$6.2M | $1.5M | $33.0K | -$544.0K | -$329.0K | $441.0K | -$12.0K | $0.00 | |
| Other Nonoperating Income Expense | $9.3M | $14.0M | $15.5M | $1.5M | $799.0K | -$174.0K | $2.2M | $316.0K | |
| Research And Development In Process | $65.0K | $75.0K | $23.4M | $3.6M | $49.7M | $5.5M | |||
| Accrued Research And Development Expenses | $21.7M | $10.5M | $7.8M | $15.6M | $16.2M | $10.4M | $19.3M | $10.7M | |
| Interest Expense | $13.5M | $13.9M | $19.4M | $12.7M | $1.9M | $12.0K | |||
| In Process Research And Development Expenses | $65.0K | $75.0K | $23.4M | $3.6M | $49.7M | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $48.5M | $114.7M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$48.2M | -$38.3M | -$36.6M | -$30.8M | $49.2M | -$41.9M | -$40.0M | -$42.5M | -$49.2M | -$59.4M | -$56.5M | -$57.8M | -$60.2M | -$59.8M | -$57.6M | -$57.8M | -$66.9M | -$54.1M | -$54.7M | -$48.5M | -$44.5M | -$32.6M | -$38.8M | -$49.4M | -$32.7M | -$26.0M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$19.0K | -$4.3M | -$2.0M | -$1.7M | $110.0K | -$278.0K | -$137.0K | -$45.0K | $138.0K | -$71.0K | -$174.0K | -$385.0K | -$137.0K | $116.0K | -$441.0K | -$225.0K | $1.1M | -$763.0K | -$168.0K | $417.0K | $140.0K | $232.0K | $3.0K | |||
| Operating Income Loss | -$49.1M | -$38.8M | -$36.8M | -$33.9M | $52.1M | -$42.0M | -$40.5M | -$46.3M | -$47.9M | -$56.0M | -$53.9M | -$54.3M | -$55.7M | -$55.6M | -$53.2M | -$53.6M | -$65.3M | -$55.0M | -$55.8M | -$50.0M | -$46.3M | -$34.0M | -$39.8M | -$50.0M | -$33.0M | -$26.1M |
| Research And Development Expense Excluding Acquired In Process Cost | $45.5M | $41.6M | $38.0M | $34.9M | $35.1M | $32.4M | $31.2M | $36.3M | $37.8M | $44.5M | $42.6M | $42.3M | $43.2M | $44.3M | $41.8M | $41.8M | $38.7M | $41.4M | $40.1M | $35.7M | $25.0M | $18.9M | $7.9M | $2.6M | ||
| Operating Expenses | $62.4M | $50.3M | $46.7M | $43.4M | $43.8M | $42.0M | $40.5M | $46.3M | $47.9M | $56.0M | $53.9M | $54.3M | $55.7M | $55.6M | $53.2M | $53.6M | $65.3M | $55.0M | $50.0M | $46.3M | $34.0M | $50.0M | $33.0M | $26.1M | ||
| General And Administrative Expense | $9.4M | $8.7M | $8.7M | $8.5M | $8.7M | $9.6M | $9.3M | $10.0M | $10.1M | $11.5M | $11.3M | $12.0M | $12.5M | $11.3M | $11.3M | $11.4M | $11.7M | $10.7M | $9.8M | $9.7M | $8.0M | $22.9M | $4.6M | $2.6M | ||
| Comprehensive Income Net Of Tax | -$48.2M | -$42.5M | -$38.7M | -$32.5M | $49.3M | -$42.2M | -$40.1M | -$42.5M | -$49.0M | -$59.4M | -$56.6M | -$58.2M | -$60.4M | -$59.7M | -$58.1M | -$58.0M | -$65.8M | -$54.8M | -$48.7M | -$44.1M | -$32.5M | -$49.2M | -$32.7M | -$26.0M | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $111.0K | -$69.0K | -$110.0K | $547.0K | -$25.0K | -$159.0K | $33.0K | -$46.0K | $115.0K | $102.0K | -$36.0K | -$377.0K | -$73.0K | -$46.0K | -$69.0K | -$293.0K | $994.0K | -$676.0K | -$168.0K | $417.0K | $140.0K | $232.0K | $3.0K | |||
| Nonoperating Income Expense | $893.0K | $492.0K | $172.0K | $2.0M | $1.6M | $31.0K | $482.0K | $3.8M | -$1.2M | -$3.3M | -$2.6M | -$3.4M | -$4.6M | -$4.2M | -$4.4M | -$4.2M | -$1.5M | $893.0K | $1.5M | $1.9M | $1.4M | $622.0K | $300.0K | $89.0K | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$130.0K | -$4.2M | -$1.9M | -$2.3M | $135.0K | -$119.0K | -$170.0K | $1.0K | $23.0K | -$173.0K | -$138.0K | -$8.0K | -$64.0K | $162.0K | -$372.0K | $68.0K | $78.0K | -$87.0K | $0.00 | $0.00 | ||||||
| Other Nonoperating Income Expense | $3.0M | $2.7M | $2.6M | $4.3M | $2.7M | $2.8M | $3.4M | $6.5M | $1.7M | -$332.0K | $587.0K | -$199.0K | $115.0K | $457.0K | $149.0K | -$108.0K | $62.0K | $2.0K | $376.0K | |||||||
| Research And Development In Process | $15.0K | $15.0K | $15.0K | $20.0K | $15.0K | $15.0K | $30.0K | $275.0K | $15.0M | $2.8M | $0.00 | $1.0M | $1.0M | $8.3M | $20.0M | $20.9M | ||||||||||
| Accrued Research And Development Expenses | $17.7M | $15.6M | $14.8M | $10.3M | $10.9M | $8.9M | $12.0M | $12.1M | $11.5M | $20.7M | $14.3M | $17.0M | $13.8M | $13.2M | $11.5M | $12.2M | $13.2M | $16.8M | $19.2M | $15.3M | $12.7M | |||||
| Interest Expense | $3.1M | $3.3M | $3.4M | $3.5M | $3.5M | $3.5M | $3.5M | $4.9M | $4.8M | $4.8M | $4.7M | $2.5M | $707.0K | $19.0K | ||||||||||||
| In Process Research And Development Expenses | $0.00 | $15.0K | $20.0K | $30.0K | $2.8M | $1.0M | ||||||||||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $13.3M | $11.5M | $9.9M | $9.5M | $95.8M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$122.8M | $29.5M | $62.8M | $12.1M | $121.5M | $320.7M | $352.5M | -$120.1M | -$6.9M | -$123.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $37.7M | $46.1M | $32.1M | $112.0M | $183.5M | $486.6M | $135.1M | $105.4M | $315.0K | $60.0K |
| Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax | -$90.0K | $89.0K | $191.0K | -$75.0K | -$225.0K | -$100.0K | $331.0K | -$61.0K | ||
| Retained Earnings Accumulated Deficit | -$1.44B | -$1.27B | -$1.21B | -$1.03B | -$811.5M | -$577.5M | -$334.2M | -$153.9M | ||
| Property Plant And Equipment Net | $64.0K | $10.0K | $1.6M | $4.0M | $5.3M | $5.5M | $5.4M | $3.2M | ||
| Prepaid Expense And Other Assets Current | $18.5M | $10.0M | $10.1M | $6.2M | $6.5M | $9.1M | $7.5M | $3.1M | ||
| Other Assets Noncurrent | $408.0K | $283.0K | $618.0K | $680.0K | $1.1M | $1.0M | $1.6M | $4.3M | ||
| Marketable Securities Current | $99.2M | $248.4M | $264.3M | $143.7M | $141.8M | $26.6M | $266.7M | $123.4M | ||
| Liabilities Current | $63.4M | $45.0M | $51.6M | $49.2M | $39.9M | $38.7M | $36.9M | $20.4M | ||
| Liabilities And Stockholders Equity | $172.2M | $315.3M | $311.9M | $272.5M | $343.7M | $539.4M | $426.6M | $239.4M | ||
| Liabilities | $295.0M | $285.8M | $249.1M | $260.4M | $222.2M | $218.7M | $74.1M | $21.1M | ||
| Common Stock Value | $24.0K | $23.0K | $23.0K | $10.0K | $8.0K | $8.0K | $7.0K | $2.0K | ||
| Cash And Cash Equivalents At Carrying Value | $37.7M | $46.1M | $32.1M | $112.0M | $183.4M | $486.1M | $135.0M | $105.2M | ||
| Assets Current | $167.6M | $309.9M | $306.5M | $261.9M | $331.8M | $522.3M | $409.3M | $232.0M | ||
| Assets | $172.2M | $315.3M | $311.9M | $272.5M | $343.7M | $539.4M | $426.6M | $239.4M | ||
| Additional Paid In Capital Common Stock | $1.32B | $1.30B | $1.28B | $1.04B | $932.9M | $897.6M | $686.4M | $33.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$5.1M | $1.2M | -$350.0K | -$574.0K | $45.0K | $599.0K | $258.0K | -$61.0K | ||
| Accrued Liabilities Current | $15.8M | $15.2M | $26.7M | $20.5M | $20.4M | $20.7M | $16.7M | $7.6M | ||
| Accretion Amortization Of Discounts And Premiums Investments | $7.3M | $13.1M | $9.5M | $1.4M | -$339.0K | -$98.0K | $2.4M | $0.00 | ||
| Accounts Payable Current | $6.0M | $2.3M | $5.5M | $1.5M | $3.2M | $7.5M | $956.0K | $2.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$8.3M | $14.0M | -$79.9M | -$71.5M | -$303.2M | $351.5M | $29.7M | $105.1M | $255.0K | |
| Operating Lease Right Of Use Asset | $4.1M | $5.1M | $3.1M | $5.9M | $5.5M | $10.6M | $10.3M | |||
| Operating Lease Liability Noncurrent | $3.5M | $4.4M | $144.0K | $3.4M | $3.2M | $7.7M | $8.7M | |||
| Long Term Debt Noncurrent | $0.00 | $814.0K | $12.0M | $29.1M | $28.7M | $28.5M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $978.0K | $3.3M | $2.8M | $2.6M | $3.4M | $2.9M | ||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$806.0K | -$726.0K | $0.00 | -$20.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$82.3M | -$46.1M | -$6.3M | $54.1M | $81.5M | $26.7M | $104.6M | -$62.8M | -$28.5M | $56.4M | -$16.5M | $30.2M | $169.8M | $220.7M | $272.1M | $372.1M | $420.3M | $306.5M | $398.9M | $441.4M | $480.3M | -$91.8M | -$60.8M | -$29.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $8.9M | $26.3M | $29.0M | $28.5M | $86.9M | $38.9M | $82.6M | $37.0M | $65.2M | $153.5M | $94.3M | $139.0M | $213.5M | $343.0M | $440.0M | $462.0M | $486.1M | $111.4M | $130.7M | $148.5M | $170.8M | $141.3M | $32.3M | $79.2M |
| Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax | -$110.0K | -$159.0K | $115.0K | -$377.0K | -$69.0K | -$676.0K | $140.0K | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.39B | -$1.34B | -$1.31B | -$1.24B | -$1.20B | -$1.25B | -$1.16B | -$1.12B | -$1.08B | -$976.5M | -$917.1M | -$860.6M | -$755.3M | -$695.0M | -$635.2M | -$512.9M | -$455.1M | -$388.2M | -$279.5M | -$231.0M | -$186.5M | |||
| Property Plant And Equipment Net | $70.0K | $76.0K | $29.0K | $302.0K | $824.0K | $1.1M | $1.9M | $3.1M | $3.5M | $4.3M | $4.7M | $5.0M | $5.6M | $5.6M | $5.9M | $5.7M | $5.8M | $5.7M | $5.1M | $4.8M | $4.1M | |||
| Prepaid Expense And Other Assets Current | $14.5M | $15.4M | $11.0M | $10.6M | $12.8M | $10.9M | $12.6M | $11.3M | $8.6M | $7.6M | $10.5M | $9.1M | $7.9M | $10.5M | $12.0M | $10.8M | $8.0M | $9.3M | $5.9M | $25.6M | $16.6M | |||
| Other Assets Noncurrent | $407.0K | $383.0K | $310.0K | $283.0K | $59.0K | $613.0K | $649.0K | $770.0K | $743.0K | $629.0K | $1.3M | $1.0M | $1.1M | $1.1M | $1.0M | $861.0K | $627.0K | $634.0K | $1.4M | $1.4M | $2.1M | |||
| Marketable Securities Current | $171.3M | $186.6M | $228.9M | $298.6M | $267.6M | $205.5M | $246.3M | $125.1M | $136.6M | $150.9M | $127.8M | $132.7M | $152.5M | $63.5M | $13.6M | $93.4M | $114.3M | $234.8M | $315.8M | $315.5M | $310.4M | |||
| Liabilities Current | $62.1M | $53.6M | $48.2M | $51.1M | $45.2M | $35.8M | $42.3M | $40.1M | $40.6M | $52.6M | $44.4M | $34.6M | $35.9M | $30.0M | $29.4M | $32.6M | $27.5M | $28.4M | $33.2M | $27.5M | $25.2M | |||
| Liabilities And Stockholders Equity | $208.8M | $240.9M | $280.6M | $350.9M | $373.4M | $259.4M | $347.9M | $181.7M | $219.9M | $323.5M | $245.8M | $294.7M | $387.0M | $432.5M | $482.5M | $584.2M | $625.1M | $371.5M | $469.8M | $507.2M | $515.9M | |||
| Liabilities | $291.2M | $287.0M | $286.8M | $296.7M | $291.9M | $232.6M | $243.3M | $244.5M | $248.4M | $267.2M | $262.3M | $264.5M | $217.2M | $211.8M | $210.4M | $212.1M | $204.8M | $65.0M | $70.9M | $65.7M | $35.7M | |||
| Common Stock Value | $24.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | |||
| Cash And Cash Equivalents At Carrying Value | $8.9M | $26.3M | $29.0M | $28.5M | $86.9M | $38.9M | $82.6M | $37.0M | $65.2M | $153.5M | $94.3M | $138.9M | $213.5M | $342.5M | $439.7M | $462.0M | $486.1M | $111.4M | $130.7M | $148.5M | $170.8M | |||
| Assets Current | $204.0M | $235.9M | $275.5M | $344.3M | $370.9M | $255.3M | $341.5M | $173.4M | $210.4M | $312.0M | $232.7M | $280.8M | $374.0M | $417.0M | $465.8M | $566.2M | $608.4M | $355.4M | $452.4M | $489.6M | $497.8M | |||
| Assets | $208.8M | $240.9M | $280.6M | $350.9M | $373.4M | $259.4M | $347.9M | $181.7M | $219.9M | $323.5M | $245.8M | $294.7M | $387.0M | $432.5M | $482.5M | $584.2M | $625.1M | $371.5M | $469.8M | $507.2M | $515.9M | |||
| Additional Paid In Capital Common Stock | $1.31B | $1.30B | $1.30B | $1.29B | $1.29B | $1.28B | $1.27B | $1.06B | $1.05B | $1.03B | $901.1M | $891.1M | $924.9M | $915.4M | $907.1M | $884.7M | $874.9M | $695.2M | $678.0M | $671.9M | $666.6M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$5.1M | -$5.1M | -$824.0K | -$2.2M | -$518.0K | -$628.0K | -$618.0K | -$481.0K | -$436.0K | -$585.0K | -$514.0K | -$340.0K | $137.0K | $274.0K | $158.0K | $342.0K | $567.0K | -$505.0K | $328.0K | $496.0K | $79.0K | |||
| Accrued Liabilities Current | $19.3M | $12.6M | $12.2M | $17.4M | $16.3M | $14.6M | $17.5M | $14.3M | $14.7M | $31.5M | $26.2M | $17.0M | $20.9M | $15.9M | $16.9M | $19.5M | $14.2M | $9.0M | $11.4M | $9.2M | $7.9M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $2.7M | $3.0M | $1.5M | -$125.0K | -$66.0K | $65.0K | ||||||||||||||||||
| Accounts Payable Current | $1.1M | $1.9M | $3.4M | $3.1M | $1.0M | $2.7M | $1.3M | $2.2M | $2.7M | $363.0K | $3.9M | $592.0K | $1.2M | $895.0K | $1.1M | $865.0K | $222.0K | $2.6M | $2.6M | $3.0M | $4.5M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$17.1M | $6.8M | -$46.7M | -$44.5M | -$46.4M | -$23.7M | $65.4M | |||||||||||||||||
| Operating Lease Right Of Use Asset | $4.4M | $4.6M | $4.8M | $6.0M | $1.7M | $2.4M | $3.8M | $4.5M | $5.2M | $6.6M | $7.2M | $7.9M | $6.3M | $8.8M | $9.7M | $11.4M | $10.3M | $9.7M | $10.9M | $11.4M | $11.9M | |||
| Operating Lease Liability Noncurrent | $3.7M | $3.9M | $4.2M | $4.6M | $0.00 | $0.00 | $992.0K | $1.8M | $2.6M | $4.2M | $5.0M | $5.7M | $4.0M | $6.2M | $7.0M | $8.6M | $7.9M | $8.1M | $9.3M | $9.9M | $10.5M | |||
| Long Term Debt Noncurrent | $0.00 | $0.00 | $0.00 | $3.6M | $6.4M | $9.2M | $14.8M | $17.6M | $29.2M | $29.0M | $28.9M | $28.8M | $28.7M | $28.6M | $28.5M | $28.4M | $28.3M | |||||||
| Operating Lease Right Of Use Asset Amortization Expense | $336.0K | $727.0K | $675.0K | $645.0K | $858.0K | |||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | -$316.0K | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $24.0K | $833.0K | $1.6M | $1.8M | $1.7M | $1.4M | $917.0K | $297.0K | |
| Share Based Compensation | $10.6M | $20.6M | $28.5M | $42.6M | $32.0M | $38.7M | $20.8M | $30.9M | $32.0K |
| Net Cash Provided By Used In Operating Activities | -$171.3M | -$3.5M | -$159.2M | -$187.0M | -$188.9M | -$176.4M | -$144.8M | -$51.0M | -$5.7M |
| Net Cash Provided By Used In Financing Activities | $6.4M | -$11.5M | $190.2M | $117.1M | $3.3M | $312.5M | $321.6M | $300.9M | $6.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.5M | -$62.0K | $3.9M | -$296.0K | -$2.6M | $1.6M | $4.4M | $2.8M | $130.0K |
| Increase Decrease In Accrued Research And Development Expenses | $11.2M | $2.7M | -$7.8M | -$579.0K | $5.8M | -$8.8M | $8.6M | $10.5M | $126.0K |
| Increase Decrease In Accrued Liabilities | $1.4M | -$10.7M | -$835.0K | -$1.7M | $736.0K | $1.1M | $1.5M | $5.9M | $824.0K |
| Increase Decrease In Accounts Payable | -$2.7M | -$1.7M | $4.0M | -$1.8M | -$4.4M | $7.0M | -$1.4M | $2.1M | $57.0K |
| Net Cash Provided By Used In Investing Activities | $156.4M | $29.0M | -$111.0M | -$1.0M | -$117.4M | $215.3M | -$147.1M | -$144.7M | |
| Increase Decrease In Other Operating Assets | $125.0K | -$335.0K | -$62.0K | -$400.0K | $53.0K | -$532.0K | -$2.7M | $584.0K | |
| Increase Decrease In Employee Related Liabilities | -$784.0K | $1.7M | -$3.2M | $1.6M | -$278.0K | $1.6M | $5.2M | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $79.0K | $0.00 | $0.00 | $410.0K | $1.5M | $1.5M | $3.0M | $3.5M | |
| Payments To Acquire Marketable Securities | $227.1M | $494.8M | $441.7M | $238.1M | $152.0M | $109.0M | $499.1M | $123.5M | |
| Proceeds From Maturity Of Marketable Securities | $376.4M | $523.8M | $330.7M | $237.5M | $36.2M | $265.7M | $328.0M | $0.00 | |
| Increase Decrease In Operating Lease Liabilities | $961.0K | $3.4M | $3.0M | $2.7M | $3.6M | $2.9M | $2.1M | $0.00 | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $141.0K | -$102.0K | $110.0K | -$517.0K | -$165.0K | $9.0K | $70.0K | $0.00 | |
| Proceeds From Stock Options Exercised | $1.9M | $0.00 | $0.00 | $1.7M | $2.0M | $534.0K | $2.0M | $0.00 | |
| Payments For Proceeds From Research And Development Asset Acquisitions | $0.00 | $0.00 | $65.0K | $75.0K | $23.4M | $3.6M | $17.7M | ||
| Increase Decrease In Interest Payable Net | $0.00 | -$135.0K | -$97.0K | -$1.0K | -$28.0K | $0.00 | $0.00 | -$117.0K | $117.0K |
| Proceeds From Stock Plans | $840.0K | $629.0K | $444.0K | $1.2M | $1.3M | $1.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $6.0K | $200.0K | $300.0K | $259.0K | $400.0K | $500.0K | $465.0K | $500.0K | $500.0K | $452.0K | $500.0K | $400.0K | $416.0K | $329.0K | $169.0K | $6.0K |
| Share Based Compensation | $2.4M | $5.8M | $8.1M | $11.0M | $8.7M | $8.2M | $3.1M | $605.0K | ||||||||
| Net Cash Provided By Used In Operating Activities | -$39.7M | -$52.3M | -$53.0M | -$53.5M | -$58.9M | -$52.3M | -$27.8M | -$3.7M | ||||||||
| Net Cash Provided By Used In Financing Activities | $504.0K | -$2.6M | -$2.5M | $721.0K | $774.0K | $571.0K | $291.3M | $71.9M | ||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $926.0K | $781.0K | $2.4M | $2.6M | $2.9M | $1.8M | $3.5M | $94.0K | ||||||||
| Increase Decrease In Accrued Research And Development Expenses | $4.3M | $1.2M | -$4.1M | $753.0K | $1.1M | -$2.5M | $2.1M | -$126.0K | ||||||||
| Increase Decrease In Accrued Liabilities | $490.0K | -$9.3M | -$273.0K | $52.0K | -$729.0K | -$2.2M | -$789.0K | $441.0K | ||||||||
| Increase Decrease In Accounts Payable | -$937.0K | -$2.9M | $1.2M | -$2.5M | -$6.6M | $1.6M | $2.1M | $546.0K | ||||||||
| Net Cash Provided By Used In Investing Activities | $22.1M | $61.7M | $8.7M | $8.4M | $12.0M | $28.0M | -$198.1M | $10.7M | ||||||||
| Increase Decrease In Other Operating Assets | $27.0K | -$5.0K | $63.0K | -$61.0K | -$16.0K | -$925.0K | -$2.1M | $425.0K | ||||||||
| Increase Decrease In Employee Related Liabilities | -$5.8M | -$4.6M | -$8.1M | -$5.8M | -$6.5M | -$5.6M | -$1.6M | $593.0K | ||||||||
| Payments To Acquire Property Plant And Equipment | $26.0K | $0.00 | $0.00 | $157.0K | $802.0K | $513.0K | $347.0K | $511.0K | ||||||||
| Payments To Acquire Marketable Securities | $101.0M | $86.1M | $76.9M | $37.4M | $0.00 | $73.8M | $222.3M | |||||||||
| Proceeds From Maturity Of Marketable Securities | $123.1M | $147.8M | $85.6M | $46.0M | $12.8M | $89.1M | $20.0M | |||||||||
| Increase Decrease In Operating Lease Liabilities | $336.0K | $801.0K | $723.0K | $683.0K | -$117.0K | $566.0K | $504.0K | |||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $105.0K | -$62.0K | $72.0K | -$154.0K | -$242.0K | -$50.0K | ||||||||||
| Proceeds From Stock Options Exercised | $132.0K | $0.00 | $0.00 | $126.0K | $15.0K | $15.0K | $71.0K | |||||||||
| Payments For Proceeds From Research And Development Asset Acquisitions | $0.00 | $15.0K | $20.0K | $30.0K | $2.8M | $1.0M | -$11.2M | |||||||||
| Increase Decrease In Interest Payable Net | $2.5M | $2.5M | $2.5M | $2.5M | $2.5M | -$115.0K | ||||||||||
| Proceeds From Stock Plans | $372.0K | $348.0K | $367.0K | $595.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.75 | -$0.25 | -$1.18 | -$2.71 | -$3.13 | -$3.55 | -$3.29 | -$22.59 | -$0.74 |
| Weighted Average Number Of Shares Outstanding Basic | 228.5M | 226.2M | 152.6M | 84.6M | 74.8M | 68.5M | 54.7M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 228.5M | 226.2M | 152.6M | 84.6M | 74.8M | 68.5M | 54.7M | ||
| Earnings Per Share Basic | $-0.75 | $-0.25 | $-1.18 | $-2.71 | $-3.13 | $-3.55 | $-3.29 | ||
| Common Stock Shares Outstanding | 233.7M | 226.6M | 225.4M | 94.4M | 75.8M | 73.9M | 61.6M | 8.1M | |
| Common Stock Shares Issued | 233.7M | 226.6M | 225.4M | 94.5M | 76.5M | 75.5M | 66.3M | 15.5M | |
| Common Stock Shares Authorized | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 49.2M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.21 | -$0.17 | -$0.16 | -$0.14 | $0.22 | -$0.19 | -$0.21 | -$0.45 | -$0.52 | -$0.65 | -$0.74 | -$0.76 | -$0.80 | -$0.80 | -$0.78 | -$0.80 | -$1.00 | -$0.87 | -$0.89 | -$0.80 | -$0.74 | -$0.90 | -$4.92 | -$8.03 | -$5.52 | -$4.31 |
| Weighted Average Number Of Shares Outstanding Basic | 228.0M | 227.3M | 226.8M | 226.3M | 226.2M | 225.7M | 192.9M | 95.4M | 94.9M | 91.2M | 76.7M | 75.9M | 75.0M | 74.7M | 74.1M | 72.2M | 66.6M | 61.9M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 228.0M | 227.3M | 226.8M | 226.3M | 238.5M | 225.7M | 192.9M | 95.4M | 94.9M | 91.2M | 76.7M | 75.9M | 75.0M | 74.7M | 74.1M | 72.2M | 66.6M | 61.9M | ||||||||
| Earnings Per Share Basic | $-0.21 | $-0.17 | $-0.16 | $-0.14 | $0.22 | $-0.19 | $-0.21 | $-0.45 | $-0.52 | $-0.65 | $-0.74 | $-0.76 | $-0.80 | $-0.80 | $-0.78 | $-0.80 | $-1.00 | $-0.87 | ||||||||
| Common Stock Shares Outstanding | 231.3M | 227.3M | 227.2M | 226.6M | 226.2M | 226.2M | 225.4M | 95.5M | 95.4M | 93.9M | 76.7M | 76.6M | 75.3M | 74.8M | 74.5M | 72.5M | 72.0M | 62.1M | 61.0M | 60.5M | 60.0M | |||||
| Common Stock Shares Issued | 231.3M | 227.3M | 227.2M | 226.6M | 226.2M | 226.2M | 225.4M | 95.5M | 95.4M | 94.1M | 77.1M | 77.1M | 76.2M | 76.0M | 75.9M | 75.9M | 75.8M | 66.3M | 66.0M | 65.9M | 65.9M | |||||
| Common Stock Shares Authorized | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | 700.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.6M | $20.6M | $28.5M | $42.6M | $32.0M | $38.7M | $20.8M | $30.9M | $32.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.9M | $1.7M | $2.0M | $534.0K | $2.0M | ||||
| Investment Income Interest | $2.0M | $1.8M | $2.0M | $1.6M | $761.0K | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $840.0K | $629.0K | $444.0K | $1.2M | $1.3M | $1.3M | |||
| Amortization Of Financing Costs And Discounts | $985.0K | $1.1M | $1.3M | $1.2M | $6.7M | $3.9M | $237.0K | $0.00 | |
| Interest Paid Net | $10.0M | $10.6M | $12.3M | $12.7M | $12.7M | $7.9M | $1.5M | $119.0K | |
| Long Term Convertible Senior Notes | $198.5M | $197.5M | $196.6M | $195.7M | $150.0M | $143.6M | $0.00 | ||
| Stock Issued During Period Shares Stock Options Exercised | 1.7M | 0.00 | 0.00 | 270.7K | 325.5K | 134.8K | 419.6K | 0.00 | |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $0.00 | $83.0K | $0.00 | $15.0K | $183.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.7M | $2.6M | $2.4M | $4.8M | $5.0M | $5.8M | $6.2M | $8.2M | $8.1M | $10.1M | $10.0M | $11.0M | $7.6M | $8.1M | $8.7M | $8.9M | $8.9M | $8.2M | $5.7M | $5.1M | $3.1M | $18.2M | $1.4M | $605.0K |
| Stock Issued During Period Value Stock Options Exercised | $465.0K | $94.0K | $132.0K | $1.6M | $21.0K | $126.0K | $1.4M | $271.0K | $15.0K | $131.0K | $139.0K | $15.0K | $369.0K | $86.0K | ||||||||||
| Investment Income Interest | $687.0K | $542.0K | $294.0K | $430.0K | $1.7M | $344.0K | $405.0K | $695.0K | $587.0K | $465.0K | $300.0K | $224.0K | $191.0K | $141.0K | $193.0K | $580.0K | $898.0K | $1.6M | $1.0M | $89.0K | ||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $469.0K | $372.0K | $281.0K | $348.0K | $77.0K | $367.0K | $620.0K | $595.0K | $556.0K | $759.0K | $744.0K | $556.0K | ||||||||||||
| Amortization Of Financing Costs And Discounts | $241.0K | $293.0K | $352.0K | $292.0K | $1.6M | $89.0K | ||||||||||||||||||
| Interest Paid Net | $0.00 | $367.0K | $663.0K | $675.0K | $675.0K | $618.0K | ||||||||||||||||||
| Long Term Convertible Senior Notes | $198.3M | $198.0M | $197.8M | $197.3M | $197.1M | $196.8M | $196.4M | $196.1M | $195.9M | $195.5M | $195.3M | $195.1M | $148.4M | $146.8M | $145.2M | $142.2M | $140.7M | |||||||
| Stock Issued During Period Shares Stock Options Exercised | 112.6K | 0.00 | 39.5K | 5.7K | 4.3K | |||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $60.0K | $739.0K | $43.0K |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.